Latest Capital Investments News

Bioxyne Limited has reported a record-breaking first quarter for FY26, with revenues soaring 210% year-on-year, driven by strong demand in cannabis products and strategic European market advances.

L1 Group has successfully completed a $286 million institutional placement and a $19 million share sale, positioning itself for accelerated growth and strategic expansion. A follow-up share purchase plan aims to raise an additional $25 million from existing shareholders.

PentaNet Ltd reported a positive net operating cash flow of A$594,000 in the September 2025 quarter, bolstered by strong liquidity and ongoing investment in 5G infrastructure.

Haranga Resources has completed its acquisition of the Lincoln Gold Project in California and reported high-grade gold results from its Senegal project, backed by a $14 million capital raise to fast-track exploration and development.

L1 Group Limited has announced a $330 million equity raising to fund expansion initiatives, including new investment strategies and potential acquisitions, following its recent merger with Platinum Asset Management.

Lynas Rare Earths is set to boost its Heavy Rare Earths production with a new separation plant in Malaysia, aiming to meet rising global demand outside China. The A$180 million project will leverage Lynas’ Mt Weld deposit and local resources to supply critical materials for advanced manufacturing.

Optiscan Imaging Ltd secured $17.75 million in a fully underwritten equity raise, fueling clinical studies and regulatory preparations for its innovative medical imaging devices. The company also reported progress in international trials and strengthened its cash position to nearly $20 million.

Hillgrove Resources has accelerated production at its Nugent centre ahead of schedule, driving an 8% rise in copper output and reducing costs. A $28 million capital raise will fund further development and exploration, underpinning growth prospects.

AdAlta Limited has made significant progress in its 'East to West' cellular immunotherapy strategy, advancing licensing negotiations for its first CAR-T product and raising $1.6 million through placements to bolster its financial position.

CSL Limited has revised its financial outlook for FY26, citing lower US influenza vaccination rates and government cost controls in China, while postponing the planned demerger of its Seqirus vaccine business and announcing a major cost-saving program.

Elsight Limited has reported a landmark Q3 2025 with record revenue growth and sustained profitability, driven by booming defence budgets and expanding commercial drone markets.

Sandfire Resources reported a robust start to FY26 with copper equivalent production exceeding forecasts by nearly 5%, alongside a significant reduction in net debt and key regulatory approvals advancing its growth projects.